109 related articles for article (PubMed ID: 2535936)
1. Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term.
Leroy MJ; Cedrin I; Breuiller M; Giovagrandi Y; Ferre F
Biochem Pharmacol; 1989 Jan; 38(1):9-15. PubMed ID: 2535936
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta.
Lindgren S; Rascón A; Andersson KE; Manganiello V; Degerman E
Biochem Pharmacol; 1991 Jul; 42(3):545-52. PubMed ID: 1650216
[TBL] [Abstract][Full Text] [Related]
4. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of uterine contractions by rolipram in vitro.
Loge O
Arzneimittelforschung; 1988 Dec; 38(12):1808-10. PubMed ID: 3245853
[TBL] [Abstract][Full Text] [Related]
6. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.
Reeves ML; Leigh BK; England PJ
Biochem J; 1987 Jan; 241(2):535-41. PubMed ID: 3036066
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles.
Muller B; Stoclet JC; Lugnier C
Eur J Pharmacol; 1992 Mar; 225(3):263-72. PubMed ID: 1325367
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.
Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.
Nicholson CD; Shahid M; Bruin J; Barron E; Spiers I; de Boer J; van Amsterdam RG; Zaagsma J; Kelly JJ; Dent G
J Pharmacol Exp Ther; 1995 Aug; 274(2):678-87. PubMed ID: 7636728
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization.
Rabe KF; Tenor H; Dent G; Schudt C; Liebig S; Magnussen H
Am J Physiol; 1993 May; 264(5 Pt 1):L458-64. PubMed ID: 7684572
[TBL] [Abstract][Full Text] [Related]
11. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors.
Shahid M; van Amsterdam RG; de Boer J; ten Berge RE; Nicholson CD; Zaagsma J
Br J Pharmacol; 1991 Oct; 104(2):471-7. PubMed ID: 1665737
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
Oger S; Méhats C; Barnette MS; Ferré F; Cabrol D; Leroy MJ
Biol Reprod; 2004 Feb; 70(2):458-64. PubMed ID: 14561639
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.
Kambayashi T; Jacob CO; Zhou D; Mazurek N; Fong M; Strassmann G
J Immunol; 1995 Nov; 155(10):4909-16. PubMed ID: 7594495
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
Souness JE; Hassall GA; Parrott DP
Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
[TBL] [Abstract][Full Text] [Related]
15. Characterization by DEAE-cellulose chromatography of a single molecular form of cyclic nucleotide phosphodiesterase in the myometrium of nonpregnant women.
Leroy MJ; Blot P; Ferré F
Gynecol Obstet Invest; 1987; 24(3):190-9. PubMed ID: 2826314
[TBL] [Abstract][Full Text] [Related]
16. Uterus-relaxing effect of β2-agonists in combination with phosphodiesterase inhibitors: studies on pregnant rat in vivo and on pregnant human myometrium in vitro.
Verli J; Klukovits A; Kormányos Z; Hajagos-Tóth J; Ducza E; Seres AB; Falkay G; Gáspár R
J Obstet Gynaecol Res; 2013 Jan; 39(1):31-9. PubMed ID: 22765375
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
Dent G; Giembycz MA; Rabe KF; Barnes PJ
Br J Pharmacol; 1991 Jun; 103(2):1339-46. PubMed ID: 1653070
[TBL] [Abstract][Full Text] [Related]
19. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
Simpson AW; Reeves ML; Rink TJ
Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
Lerner U; Ransjö M; Fredholm BB
Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
